Bifidobacterium breve BB-18
Also known as: B. breve BB-18, Bifidobacterium breve, BB-18 probiotic strain
Effective Dosage
No established dose from provided studies
What the Science Says
Bifidobacterium breve BB-18 is a specific strain of probiotic bacteria belonging to the Bifidobacterium family, which naturally colonizes the human gut. Like other Bifidobacterium strains, it is thought to support gut microbiome balance, potentially aid digestion, and may play a role in immune modulation. However, no study abstracts were available for review, so any specific claims about this particular BB-18 strain's effectiveness, dosing, or timeframe cannot be confirmed from the provided data.
What It Doesn't Do
Not proven to treat any specific disease or condition based on available data. Don't assume it works the same as other Bifidobacterium strains — strain-specific effects vary widely. No confirmed evidence it boosts immunity, resolves IBS, or improves mental health for this specific strain. The 1,000 registered supplement products using it doesn't mean it's been clinically validated.
Evidence-Based Benefits
Bifidobacterium breve BB-18 is a specific strain of probiotic bacteria belonging to the Bifidobacterium family, which naturally colonizes the human gut. Like other Bifidobacterium strains, it is thought to support gut microbiome balance, potentially aid digestion, and may play a role in immune modulation. However, no study abstracts were available for review, so any specific claims about this particular BB-18 strain's effectiveness, dosing, or timeframe cannot be confirmed from the provided data.
Weak EvidenceEffective at: No established dose from provided studies
Source: auto-research
Absorption & Bioavailability
Unknown for this specific strain. Probiotic survival through the digestive tract varies by strain, formulation, and storage conditions. Enteric-coated or refrigerated products generally improve viability.
Red Flags to Watch For
- No published study abstracts were available for this specific strain — marketing claims may outpace the science
- Strain-specific probiotic research is critical; benefits from other B. breve strains cannot be assumed to apply to BB-18
- Widespread use in 1,000+ supplement products does not equal clinical proof of efficacy
- Probiotic products vary widely in CFU count, viability, and storage requirements — quality control is a major concern
- People with compromised immune systems should consult a doctor before using any live probiotic supplement
Research Sources
- General knowledge
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-04-11